LGR4 antibody (Internal Region)
Quick Overview for LGR4 antibody (Internal Region) (ABIN1043731)
Target
See all LGR4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Internal Region
-
Supplier Product No.
- 200-301-b46
-
Supplier
- Rockland
-
Purpose
- LGR4 Antibody
-
Cross-Reactivity (Details)
- This antibody is specific for human LGR4 protein.
-
Characteristics
- Synonyms: mouse anti-LGR4 antibody, mouse anti-LGR 4 antibody, leucine-rich repeat-containing G protein-coupled receptor 4
-
Purification
- Anti-LGR4 Antibody product was purified from concentrated tissue culture supernate by Protein A chromatography.
-
Sterility
- Sterile filtered
-
Immunogen
-
Immunogen: This LGR4 antibody was produced by repeated immunizations with a synthetic peptide corresponding to an internal region of human LGR4 protein. The hybridoma was produced by fusing BALB/c mouse splenocytes and mouse myeloma SP2/O cells using conventional technology.
Immunogen Type: Conjugated Peptide
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
-
Immunohistochemistry Dilution: 5 μg/mL
Application Note: Anti-LGR4 antibody has been tested by ELISA and western blotting, and is suitable in immunohistochemistry. Expect a band approximately 102 kDa in size corresponding to LGR4 protein by western blotting in the appropriate cell lysate or extract. Specific conditions for reactivity should be optimized by the end user. Use formalin-fixed paraffin-embedded sections for immunohistochemistry. No pre-treatment of sample is required.
Western Blot Dilution: 1:500 - 1:3,000
ELISA Dilution: 1:20,000 - 1:100,000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide -
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store Anti-LGR4 Monoclonal Antibody at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge antibody if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Expiry Date
- 12 months
-
-
-
Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 16, pp. 6081-6, (2008) (PubMed).
: "
-
Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 16, pp. 6081-6, (2008) (PubMed).
-
- LGR4 (Leucine-Rich Repeat Containing G Protein-Coupled Receptor 4 (LGR4))
-
Alternative Name
- LGR4
-
Background
- Background: LGR4, also known as leucine-rich repeat-containing G protein-coupled receptor 4, is a G protein-coupled receptors (GPCRs). GPCRs are membrane bound proteins that play key roles in a variety of physiologic functions. Members of the leucine-rich GPCR (LGR) family, such as GPR48, have multiple N-terminal leucine-rich repeats (LRRs) and a 7-transmembrane domain. LGR4 is an orphan GPCR reported to be expressed in steroidogenic tissues such as placenta, ovary, testis, adrenal, pancreas, prostate, and thyroid, as well as in spinal cord, stomach, heart, and kidney.
-
Gene ID
- 55366, 157694513
-
UniProt
- Q8N537
Target
-